Join us in Vienna for a comprehensive exploration of translational heart failure research. This prestigious event brings together researchers, clinicians, and industry leaders to discuss the latest advancements in understanding and treating heart failure. Key topics include novel therapeutic targets, patient care innovations, and interdisciplinary collaborations. Our team will share insights from our latest research and engage in discussions on overcoming challenges in heart failure management. Schedule a meeting with us to exchange ideas and explore collaborative opportunities.
Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology
December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
